KAYS
Price
$0.01
Change
-$0.01 (-50.00%)
Updated
Aug 15 closing price
Capitalization
469.68K
TRUFF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
11.99M
Interact to see
Advertisement

KAYS vs TRUFF

Header iconKAYS vs TRUFF Comparison
Open Charts KAYS vs TRUFFBanner chart's image
Kaya Holdings
Price$0.01
Change-$0.01 (-50.00%)
Volume$3.17K
Capitalization469.68K
Red Light Holland
Price$0.03
Change-$0.00 (-0.00%)
Volume$347.71K
Capitalization11.99M
KAYS vs TRUFF Comparison Chart in %
Loading...
KAYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KAYS vs. TRUFF commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KAYS is a StrongBuy and TRUFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (KAYS: $0.01 vs. TRUFF: $0.03)
Brand notoriety: KAYS and TRUFF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: KAYS: 13% vs. TRUFF: 115%
Market capitalization -- KAYS: $469.68K vs. TRUFF: $11.99M
KAYS [@Pharmaceuticals: Generic] is valued at $469.68K. TRUFF’s [@Pharmaceuticals: Generic] market capitalization is $11.99M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KAYS’s FA Score shows that 1 FA rating(s) are green whileTRUFF’s FA Score has 0 green FA rating(s).

  • KAYS’s FA Score: 1 green, 4 red.
  • TRUFF’s FA Score: 0 green, 5 red.
According to our system of comparison, both KAYS and TRUFF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KAYS’s TA Score shows that 5 TA indicator(s) are bullish while TRUFF’s TA Score has 3 bullish TA indicator(s).

  • KAYS’s TA Score: 5 bullish, 4 bearish.
  • TRUFF’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, KAYS is a better buy in the short-term than TRUFF.

Price Growth

KAYS (@Pharmaceuticals: Generic) experienced а -1.74% price change this week, while TRUFF (@Pharmaceuticals: Generic) price change was -15.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRUFF($12M) has a higher market cap than KAYS($470K). TRUFF YTD gains are higher at: -19.604 vs. KAYS (-59.643). KAYS has higher annual earnings (EBITDA): -1.68M vs. TRUFF (-5.18M). TRUFF has more cash in the bank: 12.5M vs. KAYS (50.7K). TRUFF has less debt than KAYS: TRUFF (1.91M) vs KAYS (9.17M). TRUFF has higher revenues than KAYS: TRUFF (5.37M) vs KAYS (14.2K).
KAYSTRUFFKAYS / TRUFF
Capitalization470K12M4%
EBITDA-1.68M-5.18M32%
Gain YTD-59.643-19.604304%
P/E Ratio3.30N/A-
Revenue14.2K5.37M0%
Total Cash50.7K12.5M0%
Total Debt9.17M1.91M480%
FUNDAMENTALS RATINGS
KAYS vs TRUFF: Fundamental Ratings
KAYS
TRUFF
OUTLOOK RATING
1..100
5550
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
47
Fair valued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9859
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRUFF's Valuation (47) in the null industry is in the same range as KAYS (52). This means that TRUFF’s stock grew similarly to KAYS’s over the last 12 months.

TRUFF's Profit vs Risk Rating (93) in the null industry is in the same range as KAYS (100). This means that TRUFF’s stock grew similarly to KAYS’s over the last 12 months.

TRUFF's SMR Rating (97) in the null industry is in the same range as KAYS (100). This means that TRUFF’s stock grew similarly to KAYS’s over the last 12 months.

TRUFF's Price Growth Rating (59) in the null industry is somewhat better than the same rating for KAYS (98). This means that TRUFF’s stock grew somewhat faster than KAYS’s over the last 12 months.

KAYS's P/E Growth Rating (1) in the null industry is significantly better than the same rating for TRUFF (100). This means that KAYS’s stock grew significantly faster than TRUFF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KAYSTRUFF
RSI
ODDS (%)
Bullish Trend 4 days ago
56%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
68%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KAYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VYNE0.35N/A
+0.26%
VYNE Therapeutics
TARS54.210.07
+0.13%
Tarsus Pharmaceuticals
CHRW121.24-0.28
-0.23%
C.H. Robinson Worldwide
PUMP4.79-0.03
-0.62%
ProPetro Holding Corp
NAUT0.71-0.01
-1.27%
Nautilus Biotechnolgy

KAYS and

Correlation & Price change

A.I.dvisor tells us that KAYS and KMDA have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KAYS and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAYS
1D Price
Change %
KAYS100%
-29.38%
KMDA - KAYS
20%
Poorly correlated
+0.68%
UPC - KAYS
5%
Poorly correlated
-1.12%
VRNOF - KAYS
3%
Poorly correlated
-19.33%
KKPCF - KAYS
2%
Poorly correlated
N/A
SHIEF - KAYS
2%
Poorly correlated
N/A
More

TRUFF and

Correlation & Price change

A.I.dvisor tells us that TRUFF and VPHIF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRUFF and VPHIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUFF
1D Price
Change %
TRUFF100%
-6.81%
VPHIF - TRUFF
8%
Poorly correlated
N/A
BGM - TRUFF
1%
Poorly correlated
-0.07%
KAYS - TRUFF
1%
Poorly correlated
-29.38%
IMCC - TRUFF
1%
Poorly correlated
N/A
KKPCF - TRUFF
1%
Poorly correlated
N/A
More